$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Inhibitory Action of the Natural Product AP1700 on the Withdrawal Syndrome of Nalbuphine 원문보기

The journal of applied pharmacology : the official journal of the Korean Society of Applied Pharmacology, v.13 no.1, 2005년, pp.13 - 19  

Kang, Jong-Seok (Graduate School of Sports Science, Korea National Sports University) ,  Lee, Hun-Kyu (Division of Drug Development, Aperio) ,  Kim, Dong-Hyun (Graduate School of Pharmacy, Chungbuk National University) ,  Yoo, Hwan-Soo (Graduate School of Pharmacy, Chungbuk National University) ,  Jang, So-Yong (Department of Neuroscience, School of Medicine, Ewha University) ,  Oh, Sei-Kwan (Department of Neuroscience, School of Medicine, Ewha University)

Abstract AI-Helper 아이콘AI-Helper

The study was undertaken to determine the antagonism of the AP1700 on the development of nalbuphine-induced tolerance and physical dependence. AP1700 is an oriental drug preparationcomposed of 5 natural products and is known to have antinarcotic action with an oral dose of 250 mg/kg in rats. AP1700 ...

주제어

AI 본문요약
AI-Helper 아이콘 AI-Helper

* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.

가설 설정

  • Western blot analysis of protein levels suggests that signal transduction system was not solely attributable to the nalbuphine-induced withdrawal syndrome. We hypothesize that the inhibitory effects of AP1700 on nalbuphine- induced physical dependence are closely related to the modulation of CREB (cyclic AMP response element-binding) protein expression.
본문요약 정보가 도움이 되었나요?

참고문헌 (28)

  1. Belcheva, M.W., Vogel, Z., Ignatova, E., Avidor-Reiss, T., Zippel, R., Levy, R, Young, E.C., Barg, I. and Coscia, C.J. (1998). Opioid modulation of extracellular signal-regulated protein kinase activity is Ras-dependent and involves $G{\beta}{\gamma}$ subunits. J. Neurochem. 70, 635-645 

  2. Berhow, M.T., Hiroi, N. and Nestler, E.J. (1996). Regulation of ERK, part of the neurotropin signal transduction cascade, in the rat meso limbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715 

  3. Chen, J.C., Smith, E.R., Cahill, M., Cohen, R. and Fishman, J.R. (1992). The opioid receptor binding of pentazocine, morphine, fentanyl, butorphanol and nalbuphine. Life Sci. 52, 389-396 

  4. Childers, S.R. (1991). Opioid receptor-coupled second messengers. Life Sci. 48, 1991-2003 

  5. Cuellar, B., Fernandez, A.P., Lizasoain, I., Moro, M.A., Lorenzo, P., Bentura, M.L., Rodrigo, J. and Leza, J.C. (2000) Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal. Psychopharmacology (Berl.) 148, 66-73 

  6. D' Amour, F.E. and Smith, D.L., (1942). A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 74-79 

  7. Davis, R.J. (1993). The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556 

  8. Ellman, G.L. (1959). Tissue sulfhydryl compounds on acute toxicity of morphinone. Arch. Biochem. Biophys. 82, 70-77 

  9. Fukunaga, K. and Miyamoto, E. (1998). Role of MAP kinase in neurons. Mol. Neurobiol. 16, 79-95 

  10. Impey, S., Obrietan, K. and Storm, D.R. (1999). Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23, 11-14 

  11. Kim, D.S., Lim, H.K, Jang, S. and Oh, S. (2003). Changes of the level of G protein ${\alpha}$ -subunit mRNA by tolerance to and withdrawal from butorphanol. Neurochem. Res. 28, 1771-1778 

  12. Koob, G.F., Sanna, P.P. and Bloom, F.E. (1998). Neuroscience of addiction. Neuron 21, 467-476 

  13. Koyuncuoglu, H., Dizdar, Y., Aricioglu, F. and Sayin, U. (1992). Efects of MK-801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behav. 43, 484-490 

  14. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S. (1982). Protective effect of sulfhydryl compounds on acute toxicity of morphinone. Life Sci. 30, 1121-1127 

  15. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S. (1982). Effect of morphinone on opiate receptor binding and morphine-elicited analgesia. Life Sci. 31, 1451-1457 

  16. Nagamatsu, K., Kido, Y., Terao, T., Ishida, T. and Toki, S.(1983). Studies on the mechanism of covalent binding of morphine metabolites to proteins in mouse. Drug Meta. Dispos. 11, 190-194 

  17. Nestler, E.J. (1996). Under siege: the brain on opiates. Neuron 16, 897-900 

  18. Nestler, E.J., Hyman, S.E. and Malenka, R.C. (2001). Signalling to the nucleus. pp 115-137. in Molecular neuropharmacology, McGraw-Hill, New York 

  19. Nestler, E.J. (1992). Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450 

  20. Noda, Y., Yamada, K., Komori, Y., Sugihara, H., Furukawa, H., Nabeshima, T. (1996) Role of nitric oxide in the development of tolerance and sensitization to behavioral effects of phencyclidine in mice. Br. J. Pharmacol. 204, 339-340 

  21. Oh, S., Kim, J.I., Chung, M.W. and Ho, I.K. (2000). Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and - withdrawing rats. Neurochem. Res. 25, 1603-1611 

  22. Ozaki, S., Narita, M., Narita, M., Ozaki, M., Khotob, J. and Suzuki, T. (2004). Role of extracellular signal-regulated kinase in the ventral tegmental area in the suppression of the morphine-induced rewarding effect in mice with sciatic nerve ligation. J. Neurosci. 88, 1389-1397 

  23. Penning, J.P., Samson, B., Baxter, A.D. (1988). Reversal of epidural morphine-induced respiratory depression and pruritus with nalbuphine. Can. J. Anaesth. 35, 599-604 

  24. Rhim, H. and Miller, R.J. (1994). Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J. Neurosci. 14, 7608-7615 

  25. Schmidt, W.K., Tam, S.W., Shotzberger, G.S., Smith, D.H. Jr, Clark, R. and Vernier, V.G. (1985). Nalbuphine. Drug Alcohol Depend. 14, 339-362 

  26. Tokuyama, S., Wakabayashi, H. and Ho, I.K. (1996) Direct evidence for a role of glutamate in the expression of opioid withdrawal syndrome. Eur. J. Pharmacol. 295, 123-129 

  27. Walker, E.A. and Young, A.M. (1993). Discriminative-stimulus effects of the low efficacy ${\mu}$ agonist nalbuphine. J. Pharmacol Exp. Ther. 267, 322-330 

  28. Zhang, Z., Xin, S.M., Wu, G.X., Zhang, W.B., Ma, L. and Pei, G. (1999). Endogenous ${\\delta}$ -opioid and $ORL_1$ receptors couple to phosphorylation and activation of p38 MAPK in NG 108-15 cells and this is regulated by protein kinase A and protein kinase C. J. Neurochem. 73, 1502-1509 

저자의 다른 논문 :

관련 콘텐츠

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로